1. Home
  2. LGND vs BBAI Comparison

LGND vs BBAI Comparison

Compare LGND & BBAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • BBAI
  • Stock Information
  • Founded
  • LGND 1987
  • BBAI 2020
  • Country
  • LGND United States
  • BBAI United States
  • Employees
  • LGND 68
  • BBAI N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • BBAI EDP Services
  • Sector
  • LGND Health Care
  • BBAI Technology
  • Exchange
  • LGND Nasdaq
  • BBAI Nasdaq
  • Market Cap
  • LGND 2.2B
  • BBAI 2.2B
  • IPO Year
  • LGND 1992
  • BBAI N/A
  • Fundamental
  • Price
  • LGND $163.73
  • BBAI $5.03
  • Analyst Decision
  • LGND Strong Buy
  • BBAI Strong Buy
  • Analyst Count
  • LGND 8
  • BBAI 3
  • Target Price
  • LGND $144.71
  • BBAI $5.83
  • AVG Volume (30 Days)
  • LGND 139.7K
  • BBAI 72.3M
  • Earning Date
  • LGND 08-05-2025
  • BBAI 08-11-2025
  • Dividend Yield
  • LGND N/A
  • BBAI N/A
  • EPS Growth
  • LGND N/A
  • BBAI N/A
  • EPS
  • LGND N/A
  • BBAI N/A
  • Revenue
  • LGND $181,488,000.00
  • BBAI $152,561,000.00
  • Revenue This Year
  • LGND $18.41
  • BBAI N/A
  • Revenue Next Year
  • LGND $18.87
  • BBAI $14.20
  • P/E Ratio
  • LGND N/A
  • BBAI N/A
  • Revenue Growth
  • LGND 53.40
  • BBAI 3.46
  • 52 Week Low
  • LGND $81.74
  • BBAI $1.29
  • 52 Week High
  • LGND $129.90
  • BBAI $10.36
  • Technical
  • Relative Strength Index (RSI)
  • LGND 74.67
  • BBAI 34.84
  • Support Level
  • LGND $158.40
  • BBAI $5.26
  • Resistance Level
  • LGND $161.89
  • BBAI $5.66
  • Average True Range (ATR)
  • LGND 3.76
  • BBAI 0.35
  • MACD
  • LGND -0.07
  • BBAI -0.09
  • Stochastic Oscillator
  • LGND 93.80
  • BBAI 15.25

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About BBAI BigBear.ai Inc.

BigBear.ai Holdings Inc is a technology-led solutions organization, that provides both software and services to its customers. Its AI-powered decision intelligence solutions are leveraged in three markets; supply chains & logistics, autonomous systems, and cybersecurity. It operates in two segments; Cyber & Engineering segment and Analytics segment. Company generate revenue by providing customers with Edge AI-powered decision intelligence solutions and services for data ingestion, data enrichment, data processing, artificial intelligence, machine learning, predictive analytics and predictive visualization. It generate revenue from providing both software and services to customers.

Share on Social Networks: